organization · Reporting owner
Forbion IV Management B.V.
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
NewAmsterdam Pharma Co N.V.
Report date December 30, 2024 · Filed January 02, 2025
Jointly reported with ForGrowth NAP B.V., Forbion Capital Fund IV Cooperatief U.A., Forbion Growth Opportunities Fund I Cooperatief U.A., Forbion Growth Management B.V.
Section 16 reporting ended · disclosed 2025-01-02. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | IndirectSee footnote | 10,656,172 |
Reported balance
After 2024-12-30 transaction · row 1
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 1 · 2024-12-30 · Sale · Disposed 29,846 · Balance 10,656,172 F1: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by NAP PoolCo B.V. ("PoolCo") on March 28, 2024. F2: Represents 13,108 shares sold on behalf of Forbion Growth Opportunities Fund I Cooperatief U.A. ("Forbion Growth I") and 16,738 shares sold on behalf of Forbion Capital Fund IV Cooperatief U.A. ("Forbion IV"). The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $25.30 to $26.10. F3: (Continued from footnote 2) The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Following the reported transaction, of the 10,656,172 Ordinary Shares beneficially owned by ForGrowth NAP B.V. ("ForGrowth"), 652,173 shares are directly owned by ForGrowth on behalf of Forbion Growth I, and 10,003,999 are held by PoolCo and are allocated to ForGrowth, of which 4,027,712 shares are beneficially owned by Forbion Growth I and 5,976,287 shares are beneficially owned by Forbion IV. F4: ForGrowth is a shareholder of PoolCo. ForGrowth is a joint investment vehicle wholly owned by Forbion Growth I and Forbion IV but does not exercise voting or dispositive power over the Ordinary Shares held on behalf of Forbion Growth I and Forbion IV. Forbion IV Management B.V. is the sole director of Forbion IV and Forbion Growth Management B.V. is the sole director of Forbion Growth I. Each of the Reporting Persons disclaims Section 16 beneficial ownership of such shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that any of the Reporting Persons are the beneficial owner of such shares for Section 16 or any other purpose. |
Filing footnotes · ownership attribution and instrument terms
F1: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by NAP PoolCo B.V. ("PoolCo") on March 28, 2024.
F2: Represents 13,108 shares sold on behalf of Forbion Growth Opportunities Fund I Cooperatief U.A. ("Forbion Growth I") and 16,738 shares sold on behalf of Forbion Capital Fund IV Cooperatief U.A. ("Forbion IV"). The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $25.30 to $26.10.
F3: (Continued from footnote 2) The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Following the reported transaction, of the 10,656,172 Ordinary Shares beneficially owned by ForGrowth NAP B.V. ("ForGrowth"), 652,173 shares are directly owned by ForGrowth on behalf of Forbion Growth I, and 10,003,999 are held by PoolCo and are allocated to ForGrowth, of which 4,027,712 shares are beneficially owned by Forbion Growth I and 5,976,287 shares are beneficially owned by Forbion IV.
F4: ForGrowth is a shareholder of PoolCo. ForGrowth is a joint investment vehicle wholly owned by Forbion Growth I and Forbion IV but does not exercise voting or dispositive power over the Ordinary Shares held on behalf of Forbion Growth I and Forbion IV. Forbion IV Management B.V. is the sole director of Forbion IV and Forbion Growth Management B.V. is the sole director of Forbion Growth I. Each of the Reporting Persons disclaims Section 16 beneficial ownership of such shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that any of the Reporting Persons are the beneficial owner of such shares for Section 16 or any other purpose.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 30, 2024 Filed Jan 2, 2025 21:15 UTC | NewAmsterdam Pharma Co N.V. NAMS · Entity 1826 | SaleOrdinary Shares | 29,846 | $25.54 | $762,174.32 |
DisclosureSEC source: 0000950170-25-000445 · ownership.xml · nonDerivative · entry 1 ForGrowth NAP B.V. · CIK 0002005407 · 10% owner Forbion Capital Fund IV Cooperatief U.A. · CIK 0001823747 · 10% owner Forbion IV Management B.V. · CIK 0002005384 · 10% owner Forbion Growth Opportunities Fund I Cooperatief U.A. · CIK 0001911047 · 10% owner Forbion Growth Management B.V. · CIK 0001918318 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 10,656,172 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by NAP PoolCo B.V. ("PoolCo") on March 28, 2024. F2 · shares: Represents 13,108 shares sold on behalf of Forbion Growth Opportunities Fund I Cooperatief U.A. ("Forbion Growth I") and 16,738 shares sold on behalf of Forbion Capital Fund IV Cooperatief U.A. ("Forbion IV"). The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $25.30 to $26.10. F3 · shares: (Continued from footnote 2) The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Following the reported transaction, of the 10,656,172 Ordinary Shares beneficially owned by ForGrowth NAP B.V. ("ForGrowth"), 652,173 shares are directly owned by ForGrowth on behalf of Forbion Growth I, and 10,003,999 are held by PoolCo and are allocated to ForGrowth, of which 4,027,712 shares are beneficially owned by Forbion Growth I and 5,976,287 shares are beneficially owned by Forbion IV. F2 · price: Represents 13,108 shares sold on behalf of Forbion Growth Opportunities Fund I Cooperatief U.A. ("Forbion Growth I") and 16,738 shares sold on behalf of Forbion Capital Fund IV Cooperatief U.A. ("Forbion IV"). The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $25.30 to $26.10. F3 · price: (Continued from footnote 2) The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Following the reported transaction, of the 10,656,172 Ordinary Shares beneficially owned by ForGrowth NAP B.V. ("ForGrowth"), 652,173 shares are directly owned by ForGrowth on behalf of Forbion Growth I, and 10,003,999 are held by PoolCo and are allocated to ForGrowth, of which 4,027,712 shares are beneficially owned by Forbion Growth I and 5,976,287 shares are beneficially owned by Forbion IV. F4 · ownership.nature: ForGrowth is a shareholder of PoolCo. ForGrowth is a joint investment vehicle wholly owned by Forbion Growth I and Forbion IV but does not exercise voting or dispositive power over the Ordinary Shares held on behalf of Forbion Growth I and Forbion IV. Forbion IV Management B.V. is the sole director of Forbion IV and Forbion Growth Management B.V. is the sole director of Forbion Growth I. Each of the Reporting Persons disclaims Section 16 beneficial ownership of such shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that any of the Reporting Persons are the beneficial owner of such shares for Section 16 or any other purpose. Read SEC document |
| December 27, 2024 Filed Dec 30, 2024 21:15 UTC | NewAmsterdam Pharma Co N.V. NAMS · Entity 1826 | SaleOrdinary Shares | 41,472 | $25.95 | $1,076,289.64 |
DisclosureSEC source: 0000950170-24-141146 · ownership.xml · nonDerivative · entry 2 ForGrowth NAP B.V. · CIK 0002005407 · 10% owner Forbion Capital Fund IV Cooperatief U.A. · CIK 0001823747 · 10% owner Forbion IV Management B.V. · CIK 0002005384 · 10% owner Forbion Growth Opportunities Fund I Cooperatief U.A. · CIK 0001911047 · 10% owner Forbion Growth Management B.V. · CIK 0001918318 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 10,686,018 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by NAP PoolCo B.V. ("PoolCo") on March 28, 2024. F5 · shares: Represents 18,215 shares sold on behalf of Forbion Growth I and 23,257 shares sold on behalf of Forbion IV. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $25.75 to $26.325. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Following the reported transaction, of the 10,686,018 Ordinary Shares beneficially owned by ForGrowth, 652,173 shares are directly owned by ForGrowth on behalf of Forbion Growth I, and 10,033,845 are held by PoolCo and are allocated to ForGrowth, of which 4,040,820 shares are beneficially owned by Forbion Growth I and 5,993,025 shares are beneficially owned by Forbion IV. F5 · price: Represents 18,215 shares sold on behalf of Forbion Growth I and 23,257 shares sold on behalf of Forbion IV. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $25.75 to $26.325. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Following the reported transaction, of the 10,686,018 Ordinary Shares beneficially owned by ForGrowth, 652,173 shares are directly owned by ForGrowth on behalf of Forbion Growth I, and 10,033,845 are held by PoolCo and are allocated to ForGrowth, of which 4,040,820 shares are beneficially owned by Forbion Growth I and 5,993,025 shares are beneficially owned by Forbion IV. F4 · ownership.nature: ForGrowth is a shareholder of PoolCo. ForGrowth is a joint investment vehicle wholly owned by Forbion Growth I and Forbion IV but does not exercise voting or dispositive power over the Ordinary Shares held on behalf of Forbion Growth I and Forbion IV. Forbion IV Management B.V. is the sole director of Forbion IV and Forbion Growth Management B.V. is the sole director of Forbion Growth I. Each of the Reporting Persons disclaims Section 16 beneficial ownership of such shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that any of the Reporting Persons are the beneficial owner of such shares for Section 16 or any other purpose. Read SEC document |
| December 26, 2024 Filed Dec 30, 2024 21:15 UTC | NewAmsterdam Pharma Co N.V. NAMS · Entity 1826 | SaleOrdinary Shares | 33,438 | $26.01 | $869,628.75 |
DisclosureSEC source: 0000950170-24-141146 · ownership.xml · nonDerivative · entry 1 ForGrowth NAP B.V. · CIK 0002005407 · 10% owner Forbion Capital Fund IV Cooperatief U.A. · CIK 0001823747 · 10% owner Forbion IV Management B.V. · CIK 0002005384 · 10% owner Forbion Growth Opportunities Fund I Cooperatief U.A. · CIK 0001911047 · 10% owner Forbion Growth Management B.V. · CIK 0001918318 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 10,727,490 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by NAP PoolCo B.V. ("PoolCo") on March 28, 2024. F2 · shares: Represents 14,686 shares sold on behalf of Forbion Growth Opportunities Fund I Cooperatief U.A. ("Forbion Growth I") and 18,752 shares sold on behalf of Forbion Capital Fund IV Cooperatief U.A. ("Forbion IV"). The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $25.705 to $26.25. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. F3 · shares: (Continued from footnote 2) Following the reported transaction, of the 10,727,490 Ordinary Shares beneficially owned by ForGrowth NAP B.V. ("ForGrowth"), 652,173 shares are directly owned by ForGrowth on behalf of Forbion Growth I, and 10,075,317 are held by PoolCo and are allocated to ForGrowth, of which 4,059,035 shares are beneficially owned by Forbion Growth I and 6,016,282 shares are beneficially owned by Forbion IV. F2 · price: Represents 14,686 shares sold on behalf of Forbion Growth Opportunities Fund I Cooperatief U.A. ("Forbion Growth I") and 18,752 shares sold on behalf of Forbion Capital Fund IV Cooperatief U.A. ("Forbion IV"). The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $25.705 to $26.25. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. F3 · price: (Continued from footnote 2) Following the reported transaction, of the 10,727,490 Ordinary Shares beneficially owned by ForGrowth NAP B.V. ("ForGrowth"), 652,173 shares are directly owned by ForGrowth on behalf of Forbion Growth I, and 10,075,317 are held by PoolCo and are allocated to ForGrowth, of which 4,059,035 shares are beneficially owned by Forbion Growth I and 6,016,282 shares are beneficially owned by Forbion IV. F4 · ownership.nature: ForGrowth is a shareholder of PoolCo. ForGrowth is a joint investment vehicle wholly owned by Forbion Growth I and Forbion IV but does not exercise voting or dispositive power over the Ordinary Shares held on behalf of Forbion Growth I and Forbion IV. Forbion IV Management B.V. is the sole director of Forbion IV and Forbion Growth Management B.V. is the sole director of Forbion Growth I. Each of the Reporting Persons disclaims Section 16 beneficial ownership of such shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that any of the Reporting Persons are the beneficial owner of such shares for Section 16 or any other purpose. Read SEC document |
| December 24, 2024 Filed Dec 26, 2024 21:15 UTC | NewAmsterdam Pharma Co N.V. NAMS · Entity 1826 | SaleOrdinary Shares | 16,164 | $25.66 | $414,831.28 |
DisclosureSEC source: 0000950170-24-140408 · ownership.xml · nonDerivative · entry 4 ForGrowth NAP B.V. · CIK 0002005407 · 10% owner Forbion Capital Fund IV Cooperatief U.A. · CIK 0001823747 · 10% owner Forbion IV Management B.V. · CIK 0002005384 · 10% owner Forbion Growth Opportunities Fund I Cooperatief U.A. · CIK 0001911047 · 10% owner Forbion Growth Management B.V. · CIK 0001918318 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 10,760,928 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by NAP PoolCo B.V. ("PoolCo") on March 28, 2024. F7 · shares: Represents 7,099 shares sold on behalf of Forbion Growth I and 9,065 shares sold on behalf of Forbion IV. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $25.23 to $26.00. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Following the reported transaction, of the 10,760,928 Ordinary Shares beneficially owned by ForGrowth, 652,173 shares are directly owned by ForGrowth on behalf of Forbion Growth I, and 10,108,755 are held by PoolCo and are allocated to ForGrowth, of which 4,073,721 shares are beneficially owned by Forbion Growth I and 6,035,034 shares are beneficially owned by Forbion IV. F7 · price: Represents 7,099 shares sold on behalf of Forbion Growth I and 9,065 shares sold on behalf of Forbion IV. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $25.23 to $26.00. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Following the reported transaction, of the 10,760,928 Ordinary Shares beneficially owned by ForGrowth, 652,173 shares are directly owned by ForGrowth on behalf of Forbion Growth I, and 10,108,755 are held by PoolCo and are allocated to ForGrowth, of which 4,073,721 shares are beneficially owned by Forbion Growth I and 6,035,034 shares are beneficially owned by Forbion IV. F4 · ownership.nature: ForGrowth is a shareholder of PoolCo. ForGrowth is a joint investment vehicle wholly owned by Forbion Growth I and Forbion IV but does not exercise voting or dispositive power over the Ordinary Shares held on behalf of Forbion Growth I and Forbion IV. Forbion IV Management B.V. is the sole director of Forbion IV and Forbion Growth Management B.V. is the sole director of Forbion Growth I. Each of the Reporting Persons disclaims Section 16 beneficial ownership of such shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that any of the Reporting Persons are the beneficial owner of such shares for Section 16 or any other purpose. Read SEC document |
| December 23, 2024 Filed Dec 26, 2024 21:15 UTC | NewAmsterdam Pharma Co N.V. NAMS · Entity 1826 | SaleOrdinary Shares | 25,132 | $25.49 | $640,624.73 |
DisclosureSEC source: 0000950170-24-140408 · ownership.xml · nonDerivative · entry 3 ForGrowth NAP B.V. · CIK 0002005407 · 10% owner Forbion Capital Fund IV Cooperatief U.A. · CIK 0001823747 · 10% owner Forbion IV Management B.V. · CIK 0002005384 · 10% owner Forbion Growth Opportunities Fund I Cooperatief U.A. · CIK 0001911047 · 10% owner Forbion Growth Management B.V. · CIK 0001918318 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 10,777,092 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by NAP PoolCo B.V. ("PoolCo") on March 28, 2024. F6 · shares: Represents 11,038 shares sold on behalf of Forbion Growth I and 14,094 shares sold on behalf of Forbion IV. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $25.00 to $25.835. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Following the reported transaction, of the 10,777,092 Ordinary Shares beneficially owned by ForGrowth, 652,173 shares are directly owned by ForGrowth on behalf of Forbion Growth I, and 10,124,919 are held by PoolCo and are allocated to ForGrowth, of which 4,080,820 shares are beneficially owned by Forbion Growth I and 6,044,099 shares are beneficially owned by Forbion IV. F6 · price: Represents 11,038 shares sold on behalf of Forbion Growth I and 14,094 shares sold on behalf of Forbion IV. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $25.00 to $25.835. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Following the reported transaction, of the 10,777,092 Ordinary Shares beneficially owned by ForGrowth, 652,173 shares are directly owned by ForGrowth on behalf of Forbion Growth I, and 10,124,919 are held by PoolCo and are allocated to ForGrowth, of which 4,080,820 shares are beneficially owned by Forbion Growth I and 6,044,099 shares are beneficially owned by Forbion IV. F4 · ownership.nature: ForGrowth is a shareholder of PoolCo. ForGrowth is a joint investment vehicle wholly owned by Forbion Growth I and Forbion IV but does not exercise voting or dispositive power over the Ordinary Shares held on behalf of Forbion Growth I and Forbion IV. Forbion IV Management B.V. is the sole director of Forbion IV and Forbion Growth Management B.V. is the sole director of Forbion Growth I. Each of the Reporting Persons disclaims Section 16 beneficial ownership of such shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that any of the Reporting Persons are the beneficial owner of such shares for Section 16 or any other purpose. Read SEC document |
| December 20, 2024 Filed Dec 26, 2024 21:15 UTC | NewAmsterdam Pharma Co N.V. NAMS · Entity 1826 | SaleOrdinary Shares | 5,629 | $26.13 | $147,071.13 |
DisclosureSEC source: 0000950170-24-140408 · ownership.xml · nonDerivative · entry 2 ForGrowth NAP B.V. · CIK 0002005407 · 10% owner Forbion Capital Fund IV Cooperatief U.A. · CIK 0001823747 · 10% owner Forbion IV Management B.V. · CIK 0002005384 · 10% owner Forbion Growth Opportunities Fund I Cooperatief U.A. · CIK 0001911047 · 10% owner Forbion Growth Management B.V. · CIK 0001918318 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 10,802,224 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by NAP PoolCo B.V. ("PoolCo") on March 28, 2024. F5 · shares: Represents 2,472 shares sold on behalf of Forbion Growth I and 3,157 shares sold on behalf of Forbion IV. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $26.02 to $26.205. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Following the reported transaction, of the 10,802,224 Ordinary Shares beneficially owned by ForGrowth, 652,173 shares are directly owned by ForGrowth on behalf of Forbion Growth I, and 10,150,051 are held by PoolCo and are allocated to ForGrowth, of which 4,091,858 shares are beneficially owned by Forbion Growth I and 6,058,193 shares are beneficially owned by Forbion IV. F5 · price: Represents 2,472 shares sold on behalf of Forbion Growth I and 3,157 shares sold on behalf of Forbion IV. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $26.02 to $26.205. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Following the reported transaction, of the 10,802,224 Ordinary Shares beneficially owned by ForGrowth, 652,173 shares are directly owned by ForGrowth on behalf of Forbion Growth I, and 10,150,051 are held by PoolCo and are allocated to ForGrowth, of which 4,091,858 shares are beneficially owned by Forbion Growth I and 6,058,193 shares are beneficially owned by Forbion IV. F4 · ownership.nature: ForGrowth is a shareholder of PoolCo. ForGrowth is a joint investment vehicle wholly owned by Forbion Growth I and Forbion IV but does not exercise voting or dispositive power over the Ordinary Shares held on behalf of Forbion Growth I and Forbion IV. Forbion IV Management B.V. is the sole director of Forbion IV and Forbion Growth Management B.V. is the sole director of Forbion Growth I. Each of the Reporting Persons disclaims Section 16 beneficial ownership of such shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that any of the Reporting Persons are the beneficial owner of such shares for Section 16 or any other purpose. Read SEC document |
| December 20, 2024 Filed Dec 26, 2024 21:15 UTC | NewAmsterdam Pharma Co N.V. NAMS · Entity 1826 | SaleOrdinary Shares | 44,143 | $25.53 | $1,126,992.86 |
DisclosureSEC source: 0000950170-24-140408 · ownership.xml · nonDerivative · entry 1 ForGrowth NAP B.V. · CIK 0002005407 · 10% owner Forbion Capital Fund IV Cooperatief U.A. · CIK 0001823747 · 10% owner Forbion IV Management B.V. · CIK 0002005384 · 10% owner Forbion Growth Opportunities Fund I Cooperatief U.A. · CIK 0001911047 · 10% owner Forbion Growth Management B.V. · CIK 0001918318 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 10,807,853 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by NAP PoolCo B.V. ("PoolCo") on March 28, 2024. F2 · shares: Represents 19,388 shares sold on behalf of Forbion Growth Opportunities Fund I Cooperatief U.A. ("Forbion Growth I") and 24,755 shares sold on behalf of Forbion Capital Fund IV Cooperatief U.A. ("Forbion IV"). The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $25.00 to $25.99. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Following the reported transaction, of the 10,807,853 Ordinary Shares beneficially owned by ForGrowth NAP B.V. ("ForGrowth"), 652,173 shares are directly owned by ForGrowth on behalf of Forbion Growth I, and 10,155,680 are held by PoolCo and are allocated to ForGrowth, F3 · shares: (Continued from footnote 2) of which 4,094,330 shares are beneficially owned by Forbion Growth I and 6,061,350 shares are beneficially owned by Forbion IV. F2 · price: Represents 19,388 shares sold on behalf of Forbion Growth Opportunities Fund I Cooperatief U.A. ("Forbion Growth I") and 24,755 shares sold on behalf of Forbion Capital Fund IV Cooperatief U.A. ("Forbion IV"). The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $25.00 to $25.99. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Following the reported transaction, of the 10,807,853 Ordinary Shares beneficially owned by ForGrowth NAP B.V. ("ForGrowth"), 652,173 shares are directly owned by ForGrowth on behalf of Forbion Growth I, and 10,155,680 are held by PoolCo and are allocated to ForGrowth, F3 · price: (Continued from footnote 2) of which 4,094,330 shares are beneficially owned by Forbion Growth I and 6,061,350 shares are beneficially owned by Forbion IV. F4 · ownership.nature: ForGrowth is a shareholder of PoolCo. ForGrowth is a joint investment vehicle wholly owned by Forbion Growth I and Forbion IV but does not exercise voting or dispositive power over the Ordinary Shares held on behalf of Forbion Growth I and Forbion IV. Forbion IV Management B.V. is the sole director of Forbion IV and Forbion Growth Management B.V. is the sole director of Forbion Growth I. Each of the Reporting Persons disclaims Section 16 beneficial ownership of such shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that any of the Reporting Persons are the beneficial owner of such shares for Section 16 or any other purpose. Read SEC document |
| December 19, 2024 Filed Dec 20, 2024 21:25 UTC | NewAmsterdam Pharma Co N.V. NAMS · Entity 1826 | SaleOrdinary Shares | 56,506 | $25.45 | $1,437,806.47 |
DisclosureSEC source: 0000950170-24-139069 · ownership.xml · nonDerivative · entry 3 ForGrowth NAP B.V. · CIK 0002005407 · 10% owner Forbion Capital Fund IV Cooperatief U.A. · CIK 0001823747 · 10% owner Forbion IV Management B.V. · CIK 0002005384 · 10% owner Forbion Growth Opportunities Fund I Cooperatief U.A. · CIK 0001911047 · 10% owner Forbion Growth Management B.V. · CIK 0001918318 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 10,851,996 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by NAP PoolCo B.V. ("PoolCo") on March 28, 2024. F6 · shares: Represents 24,817 shares sold on behalf of Forbion Growth I and 31,689 shares sold on behalf of Forbion IV. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $25.00 to $25.94. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Following the reported transaction, of the 10,851,996 Ordinary Shares beneficially owned by ForGrowth, 652,173 shares are directly owned by ForGrowth on behalf of Forbion Growth I, and 10,199,823 are held by PoolCo and are allocated to ForGrowth, of which 4,113,718 shares are beneficially owned by Forbion Growth I and 6,086,105 shares are beneficially owned by Forbion IV. F6 · price: Represents 24,817 shares sold on behalf of Forbion Growth I and 31,689 shares sold on behalf of Forbion IV. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $25.00 to $25.94. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Following the reported transaction, of the 10,851,996 Ordinary Shares beneficially owned by ForGrowth, 652,173 shares are directly owned by ForGrowth on behalf of Forbion Growth I, and 10,199,823 are held by PoolCo and are allocated to ForGrowth, of which 4,113,718 shares are beneficially owned by Forbion Growth I and 6,086,105 shares are beneficially owned by Forbion IV. F4 · ownership.nature: ForGrowth is a shareholder of PoolCo. ForGrowth is a joint investment vehicle wholly owned by Forbion Growth I and Forbion IV but does not exercise voting or dispositive power over the Ordinary Shares held on behalf of Forbion Growth I and Forbion IV. Forbion IV Management B.V. is the sole director of Forbion IV and Forbion Growth Management B.V. is the sole director of Forbion Growth I. Each of the Reporting Persons disclaims Section 16 beneficial ownership of such shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that any of the Reporting Persons are the beneficial owner of such shares for Section 16 or any other purpose. Read SEC document |
| December 18, 2024 Filed Dec 20, 2024 21:25 UTC | NewAmsterdam Pharma Co N.V. NAMS · Entity 1826 | SaleOrdinary Shares | 46,210 | $26.55 | $1,226,857.02 |
DisclosureSEC source: 0000950170-24-139069 · ownership.xml · nonDerivative · entry 2 ForGrowth NAP B.V. · CIK 0002005407 · 10% owner Forbion Capital Fund IV Cooperatief U.A. · CIK 0001823747 · 10% owner Forbion IV Management B.V. · CIK 0002005384 · 10% owner Forbion Growth Opportunities Fund I Cooperatief U.A. · CIK 0001911047 · 10% owner Forbion Growth Management B.V. · CIK 0001918318 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 10,908,502 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by NAP PoolCo B.V. ("PoolCo") on March 28, 2024. F5 · shares: Represents 20,295 shares sold on behalf of Forbion Growth I and 25,915 shares sold on behalf of Forbion IV. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $26.165 to $26.88. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Following the reported transaction, of the 10,908,502 Ordinary Shares beneficially owned by ForGrowth, 652,173 shares are directly owned by ForGrowth on behalf of Forbion Growth I, and 10,256,329 are held by PoolCo and are allocated to ForGrowth, of which 4,138,535 shares are beneficially owned by Forbion Growth I and 6,117,794 shares are beneficially owned by Forbion IV. F5 · price: Represents 20,295 shares sold on behalf of Forbion Growth I and 25,915 shares sold on behalf of Forbion IV. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $26.165 to $26.88. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Following the reported transaction, of the 10,908,502 Ordinary Shares beneficially owned by ForGrowth, 652,173 shares are directly owned by ForGrowth on behalf of Forbion Growth I, and 10,256,329 are held by PoolCo and are allocated to ForGrowth, of which 4,138,535 shares are beneficially owned by Forbion Growth I and 6,117,794 shares are beneficially owned by Forbion IV. F4 · ownership.nature: ForGrowth is a shareholder of PoolCo. ForGrowth is a joint investment vehicle wholly owned by Forbion Growth I and Forbion IV but does not exercise voting or dispositive power over the Ordinary Shares held on behalf of Forbion Growth I and Forbion IV. Forbion IV Management B.V. is the sole director of Forbion IV and Forbion Growth Management B.V. is the sole director of Forbion Growth I. Each of the Reporting Persons disclaims Section 16 beneficial ownership of such shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that any of the Reporting Persons are the beneficial owner of such shares for Section 16 or any other purpose. Read SEC document |
| December 18, 2024 Filed Dec 20, 2024 21:25 UTC | NewAmsterdam Pharma Co N.V. NAMS · Entity 1826 | SaleOrdinary Shares | 54,518 | $25.72 | $1,402,050.31 |
DisclosureSEC source: 0000950170-24-139069 · ownership.xml · nonDerivative · entry 1 ForGrowth NAP B.V. · CIK 0002005407 · 10% owner Forbion Capital Fund IV Cooperatief U.A. · CIK 0001823747 · 10% owner Forbion IV Management B.V. · CIK 0002005384 · 10% owner Forbion Growth Opportunities Fund I Cooperatief U.A. · CIK 0001911047 · 10% owner Forbion Growth Management B.V. · CIK 0001918318 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 10,954,712 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by NAP PoolCo B.V. ("PoolCo") on March 28, 2024. F2 · shares: Represents 23,944 shares sold on behalf of Forbion Growth Opportunities Fund I Cooperatief U.A. ("Forbion Growth I") and 30,574 shares sold on behalf of Forbion Capital Fund IV Cooperatief U.A. ("Forbion IV"). The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $25.165 to $26.155. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. F3 · shares: (Continued from footnote 2) Following the reported transaction, of the 10,954,712 Ordinary Shares beneficially owned by ForGrowth NAP B.V. ("ForGrowth"), 652,173 shares are directly owned by ForGrowth on behalf of Forbion Growth I, and 10,302,539 are held by PoolCo and are allocated to ForGrowth, of which 4,158,830 shares are beneficially owned by Forbion Growth I and 6,143,709 shares are beneficially owned by Forbion IV. F2 · price: Represents 23,944 shares sold on behalf of Forbion Growth Opportunities Fund I Cooperatief U.A. ("Forbion Growth I") and 30,574 shares sold on behalf of Forbion Capital Fund IV Cooperatief U.A. ("Forbion IV"). The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $25.165 to $26.155. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. F3 · price: (Continued from footnote 2) Following the reported transaction, of the 10,954,712 Ordinary Shares beneficially owned by ForGrowth NAP B.V. ("ForGrowth"), 652,173 shares are directly owned by ForGrowth on behalf of Forbion Growth I, and 10,302,539 are held by PoolCo and are allocated to ForGrowth, of which 4,158,830 shares are beneficially owned by Forbion Growth I and 6,143,709 shares are beneficially owned by Forbion IV. F4 · ownership.nature: ForGrowth is a shareholder of PoolCo. ForGrowth is a joint investment vehicle wholly owned by Forbion Growth I and Forbion IV but does not exercise voting or dispositive power over the Ordinary Shares held on behalf of Forbion Growth I and Forbion IV. Forbion IV Management B.V. is the sole director of Forbion IV and Forbion Growth Management B.V. is the sole director of Forbion Growth I. Each of the Reporting Persons disclaims Section 16 beneficial ownership of such shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that any of the Reporting Persons are the beneficial owner of such shares for Section 16 or any other purpose. Read SEC document |
| December 17, 2024 Filed Dec 18, 2024 21:15 UTC | NewAmsterdam Pharma Co N.V. NAMS · Entity 1826 | SaleOrdinary Shares | 47,736 | $26.45 | $1,262,440.58 |
DisclosureSEC source: 0000950170-24-137893 · ownership.xml · nonDerivative · entry 3 ForGrowth NAP B.V. · CIK 0002005407 · 10% owner Forbion Capital Fund IV Cooperatief U.A. · CIK 0001823747 · 10% owner Forbion IV Management B.V. · CIK 0002005384 · 10% owner Forbion Growth Opportunities Fund I Cooperatief U.A. · CIK 0001911047 · 10% owner Forbion Growth Management B.V. · CIK 0001918318 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 11,009,230 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by NAP PoolCo B.V. ("PoolCo") on March 28, 2024. F5 · shares: Represents 20,966 shares sold on behalf of Forbion Growth I and 26,770 shares sold on behalf of Forbion IV. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $26.00 to $25.855. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Following the reported transaction, of the 11,009,230 Ordinary Shares beneficially owned by ForGrowth, 652,173 shares are directly owned by ForGrowth on behalf of Forbion Growth I, and 10,357,057 are held by PoolCo and are allocated to ForGrowth, of which 4,182,774 shares are beneficially owned by Forbion Growth I and 6,174,283 shares are beneficially owned by Forbion IV. F5 · price: Represents 20,966 shares sold on behalf of Forbion Growth I and 26,770 shares sold on behalf of Forbion IV. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $26.00 to $25.855. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Following the reported transaction, of the 11,009,230 Ordinary Shares beneficially owned by ForGrowth, 652,173 shares are directly owned by ForGrowth on behalf of Forbion Growth I, and 10,357,057 are held by PoolCo and are allocated to ForGrowth, of which 4,182,774 shares are beneficially owned by Forbion Growth I and 6,174,283 shares are beneficially owned by Forbion IV. F3 · ownership.nature: ForGrowth is a shareholder of PoolCo. ForGrowth is a joint investment vehicle wholly owned by Forbion Growth I and Forbion IV but does not exercise voting or dispositive power over the Ordinary Shares held on behalf of Forbion Growth I and Forbion IV. Forbion IV Management B.V. is the sole director of Forbion IV and Forbion Growth Management B.V. is the sole director of Forbion Growth I. Each of the Reporting Persons disclaims Section 16 beneficial ownership of such shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that any of the Reporting Persons are the beneficial owner of such shares for Section 16 or any other purpose. Read SEC document |
| December 17, 2024 Filed Dec 18, 2024 21:15 UTC | NewAmsterdam Pharma Co N.V. NAMS · Entity 1826 | SaleOrdinary Shares | 66,648 | $25.60 | $1,706,315.43 |
DisclosureSEC source: 0000950170-24-137893 · ownership.xml · nonDerivative · entry 2 ForGrowth NAP B.V. · CIK 0002005407 · 10% owner Forbion Capital Fund IV Cooperatief U.A. · CIK 0001823747 · 10% owner Forbion IV Management B.V. · CIK 0002005384 · 10% owner Forbion Growth Opportunities Fund I Cooperatief U.A. · CIK 0001911047 · 10% owner Forbion Growth Management B.V. · CIK 0001918318 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 11,056,966 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by NAP PoolCo B.V. ("PoolCo") on March 28, 2024. F4 · shares: Represents 29,272 shares sold on behalf of Forbion Growth I and 37,376 shares sold on behalf of Forbion IV. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $25.00 to $25.99. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Following the reported transaction, of the 11,056,966 Ordinary Shares beneficially owned by ForGrowth, 652,173 shares are directly owned by ForGrowth on behalf of Forbion Growth I, and 10,404,793 are held by PoolCo and are allocated to ForGrowth, of which 4,203,740 shares are beneficially owned by Forbion Growth I and 6,201,053 shares are beneficially owned by Forbion IV. F4 · price: Represents 29,272 shares sold on behalf of Forbion Growth I and 37,376 shares sold on behalf of Forbion IV. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $25.00 to $25.99. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Following the reported transaction, of the 11,056,966 Ordinary Shares beneficially owned by ForGrowth, 652,173 shares are directly owned by ForGrowth on behalf of Forbion Growth I, and 10,404,793 are held by PoolCo and are allocated to ForGrowth, of which 4,203,740 shares are beneficially owned by Forbion Growth I and 6,201,053 shares are beneficially owned by Forbion IV. F3 · ownership.nature: ForGrowth is a shareholder of PoolCo. ForGrowth is a joint investment vehicle wholly owned by Forbion Growth I and Forbion IV but does not exercise voting or dispositive power over the Ordinary Shares held on behalf of Forbion Growth I and Forbion IV. Forbion IV Management B.V. is the sole director of Forbion IV and Forbion Growth Management B.V. is the sole director of Forbion Growth I. Each of the Reporting Persons disclaims Section 16 beneficial ownership of such shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that any of the Reporting Persons are the beneficial owner of such shares for Section 16 or any other purpose. Read SEC document |
| December 16, 2024 Filed Dec 18, 2024 21:15 UTC | NewAmsterdam Pharma Co N.V. NAMS · Entity 1826 | SaleOrdinary Shares | 1,096 | $25.00 | $27,400.00 |
DisclosureSEC source: 0000950170-24-137893 · ownership.xml · nonDerivative · entry 1 ForGrowth NAP B.V. · CIK 0002005407 · 10% owner Forbion Capital Fund IV Cooperatief U.A. · CIK 0001823747 · 10% owner Forbion IV Management B.V. · CIK 0002005384 · 10% owner Forbion Growth Opportunities Fund I Cooperatief U.A. · CIK 0001911047 · 10% owner Forbion Growth Management B.V. · CIK 0001918318 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 11,123,614 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by NAP PoolCo B.V. ("PoolCo") on March 28, 2024. F2 · shares: Represents 481 shares sold on behalf of Forbion Growth Opportunities Fund I Cooperatief U.A. ("Forbion Growth I") and 615 shares sold on behalf of Forbion Capital Fund IV Cooperatief U.A. ("Forbion IV"). Following the reported transaction, of the 11,123,614 Ordinary Shares beneficially owned by ForGrowth NAP B.V. ("ForGrowth"), 652,173 shares are directly owned by ForGrowth on behalf of Forbion Growth I, and 10,471,441 are held by PoolCo and are allocated to ForGrowth, of which 4,233,012 shares are beneficially owned by Forbion Growth I and 6,238,429 shares are beneficially owned by Forbion IV. F3 · ownership.nature: ForGrowth is a shareholder of PoolCo. ForGrowth is a joint investment vehicle wholly owned by Forbion Growth I and Forbion IV but does not exercise voting or dispositive power over the Ordinary Shares held on behalf of Forbion Growth I and Forbion IV. Forbion IV Management B.V. is the sole director of Forbion IV and Forbion Growth Management B.V. is the sole director of Forbion Growth I. Each of the Reporting Persons disclaims Section 16 beneficial ownership of such shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that any of the Reporting Persons are the beneficial owner of such shares for Section 16 or any other purpose. Read SEC document |
| December 13, 2024 Filed Dec 16, 2024 21:15 UTC | NewAmsterdam Pharma Co N.V. NAMS · Entity 1826 | SaleOrdinary Shares | 25,751 | $25.01 | $644,047.96 |
DisclosureSEC source: 0000950170-24-136642 · ownership.xml · nonDerivative · entry 3 ForGrowth NAP B.V. · CIK 0002005407 · 10% owner Forbion Capital Fund IV Cooperatief U.A. · CIK 0001823747 · 10% owner Forbion IV Management B.V. · CIK 0002005384 · 10% owner Forbion Growth Opportunities Fund I Cooperatief U.A. · CIK 0001911047 · 10% owner Forbion Growth Management B.V. · CIK 0001918318 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 11,124,710 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by NAP PoolCo B.V. ("PoolCo") on March 28, 2024. F6 · shares: Represents 11,310 shares sold on behalf of Forbion Growth I and 14,441 shares sold on behalf of Forbion IV. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $25.00 to $25.13. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Following the reported transaction, of the 11,124,710 Ordinary Shares beneficially owned by ForGrowth, 652,173 shares are directly owned by ForGrowth on behalf of Forbion Growth I, and 10,472,537 are held by PoolCo and are allocated to ForGrowth, of which 4,233,493 shares are beneficially owned by Forbion Growth I and 6,239,044 shares are beneficially owned by Forbion IV. F6 · price: Represents 11,310 shares sold on behalf of Forbion Growth I and 14,441 shares sold on behalf of Forbion IV. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $25.00 to $25.13. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Following the reported transaction, of the 11,124,710 Ordinary Shares beneficially owned by ForGrowth, 652,173 shares are directly owned by ForGrowth on behalf of Forbion Growth I, and 10,472,537 are held by PoolCo and are allocated to ForGrowth, of which 4,233,493 shares are beneficially owned by Forbion Growth I and 6,239,044 shares are beneficially owned by Forbion IV. F4 · ownership.nature: ForGrowth is a shareholder of PoolCo. ForGrowth is a joint investment vehicle wholly owned by Forbion Growth I and Forbion IV but does not exercise voting or dispositive power over the Ordinary Shares held on behalf of Forbion Growth I and Forbion IV. Forbion IV Management B.V. is the sole director of Forbion IV and Forbion Growth Management B.V. is the sole director of Forbion Growth I. Each of the Reporting Persons disclaims Section 16 beneficial ownership of such shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that any of the Reporting Persons are the beneficial owner of such shares for Section 16 or any other purpose. Read SEC document |
| December 12, 2024 Filed Dec 16, 2024 21:15 UTC | NewAmsterdam Pharma Co N.V. NAMS · Entity 1826 | SaleOrdinary Shares | 25,963 | $26.18 | $679,615.28 |
DisclosureSEC source: 0000950170-24-136642 · ownership.xml · nonDerivative · entry 2 ForGrowth NAP B.V. · CIK 0002005407 · 10% owner Forbion Capital Fund IV Cooperatief U.A. · CIK 0001823747 · 10% owner Forbion IV Management B.V. · CIK 0002005384 · 10% owner Forbion Growth Opportunities Fund I Cooperatief U.A. · CIK 0001911047 · 10% owner Forbion Growth Management B.V. · CIK 0001918318 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 11,150,461 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by NAP PoolCo B.V. ("PoolCo") on March 28, 2024. F5 · shares: Represents 11,403 shares sold on behalf of Forbion Growth I and 14,560 shares sold on behalf of Forbion IV. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $26.00 to $26.405. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Following the reported transaction, of the 11,150,461 Ordinary Shares beneficially owned by ForGrowth, 652,173 shares are directly owned by ForGrowth on behalf of Forbion Growth I, and 10,498,288 are held by PoolCo and are allocated to ForGrowth, of which 4,244,803 shares are beneficially owned by Forbion Growth I and 6,253,485 shares are beneficially owned by Forbion IV. F5 · price: Represents 11,403 shares sold on behalf of Forbion Growth I and 14,560 shares sold on behalf of Forbion IV. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $26.00 to $26.405. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Following the reported transaction, of the 11,150,461 Ordinary Shares beneficially owned by ForGrowth, 652,173 shares are directly owned by ForGrowth on behalf of Forbion Growth I, and 10,498,288 are held by PoolCo and are allocated to ForGrowth, of which 4,244,803 shares are beneficially owned by Forbion Growth I and 6,253,485 shares are beneficially owned by Forbion IV. F4 · ownership.nature: ForGrowth is a shareholder of PoolCo. ForGrowth is a joint investment vehicle wholly owned by Forbion Growth I and Forbion IV but does not exercise voting or dispositive power over the Ordinary Shares held on behalf of Forbion Growth I and Forbion IV. Forbion IV Management B.V. is the sole director of Forbion IV and Forbion Growth Management B.V. is the sole director of Forbion Growth I. Each of the Reporting Persons disclaims Section 16 beneficial ownership of such shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that any of the Reporting Persons are the beneficial owner of such shares for Section 16 or any other purpose. Read SEC document |
| December 12, 2024 Filed Dec 16, 2024 21:15 UTC | NewAmsterdam Pharma Co N.V. NAMS · Entity 1826 | SaleOrdinary Shares | 140,048 | $25.25 | $3,536,212.00 |
DisclosureSEC source: 0000950170-24-136642 · ownership.xml · nonDerivative · entry 1 ForGrowth NAP B.V. · CIK 0002005407 · 10% owner Forbion Capital Fund IV Cooperatief U.A. · CIK 0001823747 · 10% owner Forbion IV Management B.V. · CIK 0002005384 · 10% owner Forbion Growth Opportunities Fund I Cooperatief U.A. · CIK 0001911047 · 10% owner Forbion Growth Management B.V. · CIK 0001918318 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 11,176,424 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by NAP PoolCo B.V. ("PoolCo") on March 28, 2024. F2 · shares: Represents 61,509 shares sold on behalf of Forbion Growth Opportunities Fund I Cooperatief U.A. ("Forbion Growth I") and 78,539 shares sold on behalf of Forbion Capital Fund IV Cooperatief U.A. ("Forbion IV"). The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $25.00 to $25.995. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Following the reported transaction, of the 11,176,424 Ordinary Shares beneficially owned by ForGrowth NAP B.V. ("ForGrowth"), 652,173 shares are directly owned by ForGrowth on behalf of Forbion Growth I, and 10,524,251 are held by PoolCo and are allocated to ForGrowth, F3 · shares: (Continued from footnote 2) of which 4,256,206 shares are beneficially owned by Forbion Growth I and 6,268,045 shares are beneficially owned by Forbion IV. F2 · price: Represents 61,509 shares sold on behalf of Forbion Growth Opportunities Fund I Cooperatief U.A. ("Forbion Growth I") and 78,539 shares sold on behalf of Forbion Capital Fund IV Cooperatief U.A. ("Forbion IV"). The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $25.00 to $25.995. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Following the reported transaction, of the 11,176,424 Ordinary Shares beneficially owned by ForGrowth NAP B.V. ("ForGrowth"), 652,173 shares are directly owned by ForGrowth on behalf of Forbion Growth I, and 10,524,251 are held by PoolCo and are allocated to ForGrowth, F3 · price: (Continued from footnote 2) of which 4,256,206 shares are beneficially owned by Forbion Growth I and 6,268,045 shares are beneficially owned by Forbion IV. F4 · ownership.nature: ForGrowth is a shareholder of PoolCo. ForGrowth is a joint investment vehicle wholly owned by Forbion Growth I and Forbion IV but does not exercise voting or dispositive power over the Ordinary Shares held on behalf of Forbion Growth I and Forbion IV. Forbion IV Management B.V. is the sole director of Forbion IV and Forbion Growth Management B.V. is the sole director of Forbion Growth I. Each of the Reporting Persons disclaims Section 16 beneficial ownership of such shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that any of the Reporting Persons are the beneficial owner of such shares for Section 16 or any other purpose. Read SEC document |
| December 11, 2024 Filed Dec 12, 2024 21:15 UTC | NewAmsterdam Pharma Co N.V. NAMS · Entity 1826 | SaleOrdinary Shares | 4,894 | $27.11 | $132,671.45 |
DisclosureSEC source: 0000950170-24-135796 · ownership.xml · nonDerivative · entry 5 ForGrowth NAP B.V. · CIK 0002005407 · 10% owner Forbion Capital Fund IV Cooperatief U.A. · CIK 0001823747 · 10% owner Forbion IV Management B.V. · CIK 0002005384 · 10% owner Forbion Growth Opportunities Fund I Cooperatief U.A. · CIK 0001911047 · 10% owner Forbion Growth Management B.V. · CIK 0001918318 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 11,316,472 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by NAP PoolCo B.V. ("PoolCo") on March 28, 2024. F8 · shares: Represents 2,149 shares sold on behalf of Forbion Growth I and 2,745 shares sold on behalf of Forbion IV. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $27.09 to $27.21. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Following the reported transaction, of the 11,316,472 Ordinary Shares beneficially owned by ForGrowth, 652,173 shares are directly owned by ForGrowth on behalf of Forbion Growth I, and 10,664,299 are held by PoolCo and are allocated to ForGrowth, of which 4,317,715 shares are beneficially owned by Forbion Growth I and 6,346,584 shares are beneficially owned by Forbion IV. F8 · price: Represents 2,149 shares sold on behalf of Forbion Growth I and 2,745 shares sold on behalf of Forbion IV. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $27.09 to $27.21. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Following the reported transaction, of the 11,316,472 Ordinary Shares beneficially owned by ForGrowth, 652,173 shares are directly owned by ForGrowth on behalf of Forbion Growth I, and 10,664,299 are held by PoolCo and are allocated to ForGrowth, of which 4,317,715 shares are beneficially owned by Forbion Growth I and 6,346,584 shares are beneficially owned by Forbion IV. F4 · ownership.nature: ForGrowth is a shareholder of PoolCo. ForGrowth is a joint investment vehicle wholly owned by Forbion Growth I and Forbion IV but does not exercise voting or dispositive power over the Ordinary Shares held on behalf of Forbion Growth I and Forbion IV. Forbion IV Management B.V. is the sole director of Forbion IV and Forbion Growth Management B.V. is the sole director of Forbion Growth I. Each of the Reporting Persons disclaims Section 16 beneficial ownership of such shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that any of the Reporting Persons are the beneficial owner of such shares for Section 16 or any other purpose. Read SEC document |
| December 11, 2024 Filed Dec 12, 2024 21:15 UTC | NewAmsterdam Pharma Co N.V. NAMS · Entity 1826 | SaleOrdinary Shares | 18,583 | $26.41 | $490,684.12 |
DisclosureSEC source: 0000950170-24-135796 · ownership.xml · nonDerivative · entry 4 ForGrowth NAP B.V. · CIK 0002005407 · 10% owner Forbion Capital Fund IV Cooperatief U.A. · CIK 0001823747 · 10% owner Forbion IV Management B.V. · CIK 0002005384 · 10% owner Forbion Growth Opportunities Fund I Cooperatief U.A. · CIK 0001911047 · 10% owner Forbion Growth Management B.V. · CIK 0001918318 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 11,321,366 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by NAP PoolCo B.V. ("PoolCo") on March 28, 2024. F7 · shares: Represents 8,162 shares sold on behalf of Forbion Growth I and 10,421 shares sold on behalf of Forbion IV. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $26.00 to $26.80. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Following the reported transaction, of the 11,321,366 Ordinary Shares beneficially owned by ForGrowth, 652,173 shares are directly owned by ForGrowth on behalf of Forbion Growth I, and 10,669,193 are held by PoolCo and are allocated to ForGrowth, of which 4,319,864 shares are beneficially owned by Forbion Growth I and 6,349,329 shares are beneficially owned by Forbion IV. F7 · price: Represents 8,162 shares sold on behalf of Forbion Growth I and 10,421 shares sold on behalf of Forbion IV. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $26.00 to $26.80. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Following the reported transaction, of the 11,321,366 Ordinary Shares beneficially owned by ForGrowth, 652,173 shares are directly owned by ForGrowth on behalf of Forbion Growth I, and 10,669,193 are held by PoolCo and are allocated to ForGrowth, of which 4,319,864 shares are beneficially owned by Forbion Growth I and 6,349,329 shares are beneficially owned by Forbion IV. F4 · ownership.nature: ForGrowth is a shareholder of PoolCo. ForGrowth is a joint investment vehicle wholly owned by Forbion Growth I and Forbion IV but does not exercise voting or dispositive power over the Ordinary Shares held on behalf of Forbion Growth I and Forbion IV. Forbion IV Management B.V. is the sole director of Forbion IV and Forbion Growth Management B.V. is the sole director of Forbion Growth I. Each of the Reporting Persons disclaims Section 16 beneficial ownership of such shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that any of the Reporting Persons are the beneficial owner of such shares for Section 16 or any other purpose. Read SEC document |
| December 11, 2024 Filed Dec 12, 2024 21:15 UTC | NewAmsterdam Pharma Co N.V. NAMS · Entity 1826 | SaleOrdinary Shares | 130,561 | $25.26 | $3,298,453.94 |
DisclosureSEC source: 0000950170-24-135796 · ownership.xml · nonDerivative · entry 3 ForGrowth NAP B.V. · CIK 0002005407 · 10% owner Forbion Capital Fund IV Cooperatief U.A. · CIK 0001823747 · 10% owner Forbion IV Management B.V. · CIK 0002005384 · 10% owner Forbion Growth Opportunities Fund I Cooperatief U.A. · CIK 0001911047 · 10% owner Forbion Growth Management B.V. · CIK 0001918318 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 11,339,949 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by NAP PoolCo B.V. ("PoolCo") on March 28, 2024. F6 · shares: Represents 57,342 shares sold on behalf of Forbion Growth I and 73,219 shares sold on behalf of Forbion IV. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $25.00 to $25.995. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Following the reported transaction, of the 11,339,949 Ordinary Shares beneficially owned by ForGrowth, 652,173 shares are directly owned by ForGrowth on behalf of Forbion Growth I, and 10,687,776 are held by PoolCo and are allocated to ForGrowth, of which 4,328,026 shares are beneficially owned by Forbion Growth I and 6,359,750 shares are beneficially owned by Forbion IV. F6 · price: Represents 57,342 shares sold on behalf of Forbion Growth I and 73,219 shares sold on behalf of Forbion IV. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $25.00 to $25.995. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Following the reported transaction, of the 11,339,949 Ordinary Shares beneficially owned by ForGrowth, 652,173 shares are directly owned by ForGrowth on behalf of Forbion Growth I, and 10,687,776 are held by PoolCo and are allocated to ForGrowth, of which 4,328,026 shares are beneficially owned by Forbion Growth I and 6,359,750 shares are beneficially owned by Forbion IV. F4 · ownership.nature: ForGrowth is a shareholder of PoolCo. ForGrowth is a joint investment vehicle wholly owned by Forbion Growth I and Forbion IV but does not exercise voting or dispositive power over the Ordinary Shares held on behalf of Forbion Growth I and Forbion IV. Forbion IV Management B.V. is the sole director of Forbion IV and Forbion Growth Management B.V. is the sole director of Forbion Growth I. Each of the Reporting Persons disclaims Section 16 beneficial ownership of such shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that any of the Reporting Persons are the beneficial owner of such shares for Section 16 or any other purpose. Read SEC document |
| December 10, 2024 Filed Dec 12, 2024 21:15 UTC | NewAmsterdam Pharma Co N.V. NAMS · Entity 1826 | SaleOrdinary Shares | 48,511 | $26.15 | $1,268,606.31 |
DisclosureSEC source: 0000950170-24-135796 · ownership.xml · nonDerivative · entry 2 ForGrowth NAP B.V. · CIK 0002005407 · 10% owner Forbion Capital Fund IV Cooperatief U.A. · CIK 0001823747 · 10% owner Forbion IV Management B.V. · CIK 0002005384 · 10% owner Forbion Growth Opportunities Fund I Cooperatief U.A. · CIK 0001911047 · 10% owner Forbion Growth Management B.V. · CIK 0001918318 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 11,470,510 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by NAP PoolCo B.V. ("PoolCo") on March 28, 2024. F5 · shares: Represents 21,306 shares sold on behalf of Forbion Growth I and 27,205 shares sold on behalf of Forbion IV. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $26.00 to $26.33. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Following the reported transaction, of the 11,470,510 Ordinary Shares beneficially owned by ForGrowth, 652,173 shares are directly owned by ForGrowth on behalf of Forbion Growth I, and 10,818,337 are held by PoolCo and are allocated to ForGrowth, of which 4,385,368 shares are beneficially owned by Forbion Growth I and 6,432,969 shares are beneficially owned by Forbion IV. F5 · price: Represents 21,306 shares sold on behalf of Forbion Growth I and 27,205 shares sold on behalf of Forbion IV. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $26.00 to $26.33. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Following the reported transaction, of the 11,470,510 Ordinary Shares beneficially owned by ForGrowth, 652,173 shares are directly owned by ForGrowth on behalf of Forbion Growth I, and 10,818,337 are held by PoolCo and are allocated to ForGrowth, of which 4,385,368 shares are beneficially owned by Forbion Growth I and 6,432,969 shares are beneficially owned by Forbion IV. F4 · ownership.nature: ForGrowth is a shareholder of PoolCo. ForGrowth is a joint investment vehicle wholly owned by Forbion Growth I and Forbion IV but does not exercise voting or dispositive power over the Ordinary Shares held on behalf of Forbion Growth I and Forbion IV. Forbion IV Management B.V. is the sole director of Forbion IV and Forbion Growth Management B.V. is the sole director of Forbion Growth I. Each of the Reporting Persons disclaims Section 16 beneficial ownership of such shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that any of the Reporting Persons are the beneficial owner of such shares for Section 16 or any other purpose. Read SEC document |
| December 10, 2024 Filed Dec 12, 2024 21:15 UTC | NewAmsterdam Pharma Co N.V. NAMS · Entity 1826 | SaleOrdinary Shares | 259,739 | $25.22 | $6,550,202.00 |
DisclosureSEC source: 0000950170-24-135796 · ownership.xml · nonDerivative · entry 1 ForGrowth NAP B.V. · CIK 0002005407 · 10% owner Forbion Capital Fund IV Cooperatief U.A. · CIK 0001823747 · 10% owner Forbion IV Management B.V. · CIK 0002005384 · 10% owner Forbion Growth Opportunities Fund I Cooperatief U.A. · CIK 0001911047 · 10% owner Forbion Growth Management B.V. · CIK 0001918318 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 11,519,021 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by NAP PoolCo B.V. ("PoolCo") on March 28, 2024. F2 · shares: Represents 114,077 shares sold on behalf of Forbion Growth Opportunities Fund I Cooperatief U.A. ("Forbion Growth I") and 145,662 shares sold on behalf of Forbion Capital Fund IV Cooperatief U.A. ("Forbion IV"). The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $25.00 to $25.99. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Following the reported transaction, of the 11,519,021 Ordinary Shares beneficially owned by ForGrowth NAP B.V. ("ForGrowth"), 652,173 shares are directly owned by ForGrowth on behalf of Forbion Growth I, and 10,866,848 are held by PoolCo and are allocated to ForGrowth, F3 · shares: (Continued from footnote 2) of which 4,406,674 shares are beneficially owned by Forbion Growth I and 6,460,174 shares are beneficially owned by Forbion IV. F2 · price: Represents 114,077 shares sold on behalf of Forbion Growth Opportunities Fund I Cooperatief U.A. ("Forbion Growth I") and 145,662 shares sold on behalf of Forbion Capital Fund IV Cooperatief U.A. ("Forbion IV"). The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $25.00 to $25.99. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Following the reported transaction, of the 11,519,021 Ordinary Shares beneficially owned by ForGrowth NAP B.V. ("ForGrowth"), 652,173 shares are directly owned by ForGrowth on behalf of Forbion Growth I, and 10,866,848 are held by PoolCo and are allocated to ForGrowth, F3 · price: (Continued from footnote 2) of which 4,406,674 shares are beneficially owned by Forbion Growth I and 6,460,174 shares are beneficially owned by Forbion IV. F4 · ownership.nature: ForGrowth is a shareholder of PoolCo. ForGrowth is a joint investment vehicle wholly owned by Forbion Growth I and Forbion IV but does not exercise voting or dispositive power over the Ordinary Shares held on behalf of Forbion Growth I and Forbion IV. Forbion IV Management B.V. is the sole director of Forbion IV and Forbion Growth Management B.V. is the sole director of Forbion Growth I. Each of the Reporting Persons disclaims Section 16 beneficial ownership of such shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that any of the Reporting Persons are the beneficial owner of such shares for Section 16 or any other purpose. Read SEC document |
| November 18, 2024 Filed Nov 19, 2024 21:15 UTC | NewAmsterdam Pharma Co N.V. NAMS · Entity 1826 | SaleOrdinary Shares | 33,273 | $25.08 | $834,440.26 |
DisclosureSEC source: 0000950170-24-128607 · ownership.xml · nonDerivative · entry 2 ForGrowth NAP B.V. · CIK 0002005407 · 10% owner Forbion Capital Fund IV Cooperatief U.A. · CIK 0001823747 · 10% owner Forbion IV Management B.V. · CIK 0002005384 · 10% owner Forbion Growth Opportunities Fund I Cooperatief U.A. · CIK 0001911047 · 10% owner Forbion Growth Management B.V. · CIK 0001918318 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 11,778,760 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by NAP PoolCo B.V. ("PoolCo") on March 28, 2024. F5 · shares: Represents 14,614 shares sold on behalf of Forbion Growth I and 18,659 shares sold on behalf of Forbion IV. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $25.00 to $25.28. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Following the reported transaction, of the 11,778,760 Ordinary Shares beneficially owned by ForGrowth, 652,173 shares are directly owned by ForGrowth on behalf of Forbion Growth I, and 11,126,587 are held by PoolCo and are allocated to ForGrowth, of which in 4,520,751 shares are beneficially owned by Forbion Growth I and 6,605,836 shares are beneficially owned by Forbion IV. F5 · price: Represents 14,614 shares sold on behalf of Forbion Growth I and 18,659 shares sold on behalf of Forbion IV. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $25.00 to $25.28. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Following the reported transaction, of the 11,778,760 Ordinary Shares beneficially owned by ForGrowth, 652,173 shares are directly owned by ForGrowth on behalf of Forbion Growth I, and 11,126,587 are held by PoolCo and are allocated to ForGrowth, of which in 4,520,751 shares are beneficially owned by Forbion Growth I and 6,605,836 shares are beneficially owned by Forbion IV. F4 · ownership.nature: ForGrowth is a shareholder of PoolCo. ForGrowth is a joint investment vehicle wholly owned by Forbion Growth I and Forbion IV but does not exercise voting or dispositive power over the Ordinary Shares held on behalf of Forbion Growth I and Forbion IV. Forbion IV Management B.V. is the sole director of Forbion IV and Forbion Growth Management B.V. is the sole director of Forbion Growth I. Each of the Reporting Persons disclaims Section 16 beneficial ownership of such shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that any of the Reporting Persons are the beneficial owner of such shares for Section 16 or any other purpose. Read SEC document |
| November 15, 2024 Filed Nov 19, 2024 21:15 UTC | NewAmsterdam Pharma Co N.V. NAMS · Entity 1826 | SaleOrdinary Shares | 8,530 | $25.02 | $213,435.95 |
DisclosureSEC source: 0000950170-24-128607 · ownership.xml · nonDerivative · entry 1 ForGrowth NAP B.V. · CIK 0002005407 · 10% owner Forbion Capital Fund IV Cooperatief U.A. · CIK 0001823747 · 10% owner Forbion IV Management B.V. · CIK 0002005384 · 10% owner Forbion Growth Opportunities Fund I Cooperatief U.A. · CIK 0001911047 · 10% owner Forbion Growth Management B.V. · CIK 0001918318 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 11,812,033 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by NAP PoolCo B.V. ("PoolCo") on March 28, 2024. F2 · shares: Represents 3,746 shares sold on behalf of Forbion Growth Opportunities Fund I Cooperatief U.A. ("Forbion Growth I") and 4,784 shares sold on behalf of Forbion Capital Fund IV Cooperatief U.A. ("Forbion IV"). The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $25.00 to $25.115. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. F3 · shares: (Continued from footnote 2) Following the reported transaction, of the 11,812,033 Ordinary Shares beneficially owned by ForGrowth NAP B.V. ("ForGrowth"), 652,173 shares are directly owned by ForGrowth on behalf of Forbion Growth I, and 11,159,860 are held by PoolCo and are allocated to ForGrowth, of which in 4,535,365 shares are beneficially owned by Forbion Growth I and 6,624,495 shares are beneficially owned by Forbion IV. F2 · price: Represents 3,746 shares sold on behalf of Forbion Growth Opportunities Fund I Cooperatief U.A. ("Forbion Growth I") and 4,784 shares sold on behalf of Forbion Capital Fund IV Cooperatief U.A. ("Forbion IV"). The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $25.00 to $25.115. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. F3 · price: (Continued from footnote 2) Following the reported transaction, of the 11,812,033 Ordinary Shares beneficially owned by ForGrowth NAP B.V. ("ForGrowth"), 652,173 shares are directly owned by ForGrowth on behalf of Forbion Growth I, and 11,159,860 are held by PoolCo and are allocated to ForGrowth, of which in 4,535,365 shares are beneficially owned by Forbion Growth I and 6,624,495 shares are beneficially owned by Forbion IV. F4 · ownership.nature: ForGrowth is a shareholder of PoolCo. ForGrowth is a joint investment vehicle wholly owned by Forbion Growth I and Forbion IV but does not exercise voting or dispositive power over the Ordinary Shares held on behalf of Forbion Growth I and Forbion IV. Forbion IV Management B.V. is the sole director of Forbion IV and Forbion Growth Management B.V. is the sole director of Forbion Growth I. Each of the Reporting Persons disclaims Section 16 beneficial ownership of such shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that any of the Reporting Persons are the beneficial owner of such shares for Section 16 or any other purpose. Read SEC document |
| November 14, 2024 Filed Nov 15, 2024 21:36 UTC | NewAmsterdam Pharma Co N.V. NAMS · Entity 1826 | SaleOrdinary Shares | 9,832 | $25.01 | $245,856.04 |
DisclosureSEC source: 0000950170-24-127643 · ownership.xml · nonDerivative · entry 2 ForGrowth NAP B.V. · CIK 0002005407 · 10% owner Forbion Capital Fund IV Cooperatief U.A. · CIK 0001823747 · 10% owner Forbion IV Management B.V. · CIK 0002005384 · 10% owner Forbion Growth Opportunities Fund I Cooperatief U.A. · CIK 0001911047 · 10% owner Forbion Growth Management B.V. · CIK 0001918318 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 11,820,563 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by NAP PoolCo B.V. ("PoolCo") on March 28, 2024. F5 · shares: Represents 4,318 shares sold on behalf of Forbion Growth I and 5,514 shares sold on behalf of Forbion IV. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $25.00 to $25.10. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Following the reported transaction, of the 11,820,563 Ordinary Shares beneficially owned by ForGrowth, 652,173 shares are directly owned by ForGrowth on behalf of Forbion Growth I, and 11,168,390 are held by PoolCo and are allocated to ForGrowth NAP B.V, of which 4,539,111 shares are beneficially owned by Forbion Growth I and 6,629,279 shares are beneficially owned by Forbion IV. F5 · price: Represents 4,318 shares sold on behalf of Forbion Growth I and 5,514 shares sold on behalf of Forbion IV. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $25.00 to $25.10. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Following the reported transaction, of the 11,820,563 Ordinary Shares beneficially owned by ForGrowth, 652,173 shares are directly owned by ForGrowth on behalf of Forbion Growth I, and 11,168,390 are held by PoolCo and are allocated to ForGrowth NAP B.V, of which 4,539,111 shares are beneficially owned by Forbion Growth I and 6,629,279 shares are beneficially owned by Forbion IV. F4 · ownership.nature: ForGrowth is a shareholder of PoolCo. ForGrowth is a joint investment vehicle wholly owned by Forbion Growth Opportunities Fund I Cooperatief U.A. ("Forbion Growth I") and Forbion Capital Fund IV Cooperatief U.A. ("Forbion IV"), but does not exercise voting or dispositive power over the Ordinary Shares held by PoolCo on behalf of Forbion Growth I and Forbion IV. Forbion IV Management B.V. is the sole director of Forbion IV and Forbion Growth Management B.V. is the sole director of Forbion Growth I. Each of the Reporting Persons disclaims Section 16 beneficial ownership of such shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that any of the Reporting Persons are the beneficial owner of such shares for Section 16 or any other purpose. Read SEC document |
| November 13, 2024 Filed Nov 15, 2024 21:36 UTC | NewAmsterdam Pharma Co N.V. NAMS · Entity 1826 | SaleOrdinary Shares | 1,066 | $25.00 | $26,654.58 |
DisclosureSEC source: 0000950170-24-127643 · ownership.xml · nonDerivative · entry 1 ForGrowth NAP B.V. · CIK 0002005407 · 10% owner Forbion Capital Fund IV Cooperatief U.A. · CIK 0001823747 · 10% owner Forbion IV Management B.V. · CIK 0002005384 · 10% owner Forbion Growth Opportunities Fund I Cooperatief U.A. · CIK 0001911047 · 10% owner Forbion Growth Management B.V. · CIK 0001918318 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 11,830,395 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by NAP PoolCo B.V. ("PoolCo") on March 28, 2024. F2 · shares: Represents 468 shares sold on behalf of Forbion Growth Opportunities Fund I Cooperatief U.A. ("Forbion Growth I") and 598 shares sold on behalf of Forbion Capital Fund IV Cooperatief U.A. ("Forbion IV"). The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $25.00 to $25.06. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. F3 · shares: (Continued from footnote 2) Following the reported transaction, of the 11,830,395 Ordinary Shares beneficially owned by ForGrowth NAP B.V. ("ForGrowth"), 652,173 shares are directly owned by ForGrowth on behalf of Forbion Growth I, and 11,178,222 are held by PoolCo and are allocated to ForGrowth NAP B.V., of which in 4,543,429 shares are beneficially owned by Forbion Growth I and 6,634,793 shares are beneficially owned by Forbion IV. F2 · price: Represents 468 shares sold on behalf of Forbion Growth Opportunities Fund I Cooperatief U.A. ("Forbion Growth I") and 598 shares sold on behalf of Forbion Capital Fund IV Cooperatief U.A. ("Forbion IV"). The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $25.00 to $25.06. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. F3 · price: (Continued from footnote 2) Following the reported transaction, of the 11,830,395 Ordinary Shares beneficially owned by ForGrowth NAP B.V. ("ForGrowth"), 652,173 shares are directly owned by ForGrowth on behalf of Forbion Growth I, and 11,178,222 are held by PoolCo and are allocated to ForGrowth NAP B.V., of which in 4,543,429 shares are beneficially owned by Forbion Growth I and 6,634,793 shares are beneficially owned by Forbion IV. F4 · ownership.nature: ForGrowth is a shareholder of PoolCo. ForGrowth is a joint investment vehicle wholly owned by Forbion Growth Opportunities Fund I Cooperatief U.A. ("Forbion Growth I") and Forbion Capital Fund IV Cooperatief U.A. ("Forbion IV"), but does not exercise voting or dispositive power over the Ordinary Shares held by PoolCo on behalf of Forbion Growth I and Forbion IV. Forbion IV Management B.V. is the sole director of Forbion IV and Forbion Growth Management B.V. is the sole director of Forbion Growth I. Each of the Reporting Persons disclaims Section 16 beneficial ownership of such shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that any of the Reporting Persons are the beneficial owner of such shares for Section 16 or any other purpose. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.